Page last updated: 2024-10-28

hydroxyzine and Disease Exacerbation

hydroxyzine has been researched along with Disease Exacerbation in 2 studies

Hydroxyzine: A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
hydroxyzine : A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.

Research Excerpts

ExcerptRelevanceReference
"The causes of pruritus are numerous including xerosis, drug and photoeruptions, follicular and papular eruptions as well as infestations and infections by a wide range of organisms."2.68Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation. ( Lee, RB; Skelton, HG; Smith, KJ; Wagner, KF; Yeager, J, 1997)
"Interstitial cystitis is more common than previously thought and is often diagnosed only when pain, frequency, and urgency become continuous and severe."2.43Interstitial cystitis: a primary care perspective. ( Page, S; Parsons, CL; Rosenberg, M, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenberg, M1
Parsons, CL1
Page, S1
Smith, KJ1
Skelton, HG1
Yeager, J1
Lee, RB1
Wagner, KF1

Reviews

1 review available for hydroxyzine and Disease Exacerbation

ArticleYear
Interstitial cystitis: a primary care perspective.
    Cleveland Clinic journal of medicine, 2005, Volume: 72, Issue:8

    Topics: Amitriptyline; Cystitis, Interstitial; Disease Progression; Humans; Hydroxyzine; Primary Health Care

2005

Trials

1 trial available for hydroxyzine and Disease Exacerbation

ArticleYear
Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation.
    Dermatology (Basel, Switzerland), 1997, Volume: 195, Issue:4

    Topics: Administration, Cutaneous; Administration, Topical; Anti-Inflammatory Agents; Antipruritics; Cycloox

1997